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Abstract.
Background: Results of a dynamic multimodality mapping study showed no lymphatic drainage of the lateral bladder wall to
the contralateral internal iliac region.
Objectives: To validate whether pathoanatomical mapping in bladder cancer (BC) patients can confirm these results.
Methods: Between 01/2000 and 07/2013, 825 BC patients preoperatively staged ≥pT1 and without clinical signs of metastases
(cN0 cM0) underwent extended pelvic lymph node dissection (ePLND) and radical cystectomy at our department. Of these
patients, 23% (193/825) were lymph node (LN) positive in the pathological specimen; 26% (51/193) of this subgroup had
strictly unilateral BC. Pathoanatomical mapping was used to retrospectively validate the distribution of LN involvement in these
51 patients.
Results: A median of 35 LNs were removed per patient (range: 13–80 LNs), with a median of 2 positive LNs (range: 1–14 LNs).
27% (14/51) of patients presented with LN metastases on the contralateral side. No positive LNs were found in the contralateral
internal iliac region or the contralateral fossa of Marcille. 10% (5/51) of patients had LN metastases only on the contralateral
side without evidence of metastases on the tumor-bearing side.
Conclusions: Our findings corroborate the data of a dynamic mapping study showing bilateral lymphatic drainage in almost one
third of patients with strictly unilateral BC, but no lymphatic drainage from the lateral bladder wall to the contralateral internal
iliac region. If prospective studies confirm these results, the contralateral internal iliac region may be omitted during ePLND in
patients with strictly unilateral BC.
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INTRODUCTION
Two thirds of surgically treated patients with bladder
cancer (BC) and lymph node (LN) metastases (pN+)
1These authors contributed equally to this work.
∗Correspondence to: Beat Roth, Department of Urology, Univer-
sity of Bern, 3010 Bern, Switzerland. Tel.: +41316323641; Fax:
+41316322181; E-mail: Urology.Berne@insel.ch.
will die from cancer [1]. Skinner has shown that 30%
of patients with only a few LN metastases can be cured
by a meticulous LN dissection [2]. This suggests that
in patients with invasive BC a bilateral extended pelvic
lymph node dissection (ePLND) should be the minimal
standard for optimal local and systemic oncologic con-
trol [3]. A recently published dynamic mapping study
by Roth et al. [4] defined the standard PLND tem-
plate as comprising the LNs along the common iliac
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artery up to where the ureter crosses the vessel, LNs
above, below, and lateral to the external iliac artery
and vein, the obturator fossa, and LNs medial and lat-
eral to the internal iliac vessels. In fact, this template
was already described by Whitmore and Marshall in
1962 [5]. In their dynamic mapping study, however,
Roth et al. could show that almost half (42%) of the
internal iliac nodes are located medial to the hypogas-
tric artery [4]. Dissection and removal of these LNs
- called by some authors presacral LNs - bears the
risk of harm to the autonomic nerves, threatening both
continence and sexual function [6–12]. Since dynamic
multimodality LN mapping has shown a drainage to
the contralateral side in 40% of BC patients [4], a
bilateral ePLND would appear to be mandatory in
all BC patients, thus increasing the risk of negatively
influencing autonomic nerve function. However, injec-
tion of radioactive tracer into the lateral bladder wall
(non-tumor-bearing side) revealed no drainage to the
contralateral internal iliac region [13]. We therefore
used pathoanatomical mapping to validate the dynamic
multimodality mapping findings suggesting that in
strictly unilateral BC the contralateral internal iliac
region may be omitted during PLND without compro-
mising oncological radicality.
MATERIAL AND METHODS
A total of 825 BC patients preoperatively staged
≥pT1 cN0 cM0 (physical examination, chest X-ray,
abdominal and pelvic computerized tomography [CT]
or magnetic resonance imaging [MRI], and bone scan)
underwent ePLND and radical cystectomy at our insti-
tution between January 2000 and July 2013. Of these
825 patients, 193 (23%) were found to have LN metas-
tases upon pathological examination. None of these
patients received neoadjuvant chemotherapy or neoad-
juvant radiotherapy. Analysis of the localization of
the primary tumor showed 51 pN+ patients to have
strictly unilateral BC (lateral bladder wall) (Fig. 1,
showing the institutional protocol of the anatomic
tumor localization). The unilaterality was confirmed
by reviewing the preoperative imaging (CT or MRI) of
the pelvis and preoperative cystoscopy images/reports.
It was confirmed by a review of pathology reports. All
51 pN+ patients had muscle-invasive disease (≥pT2),
49 (96%) had poorly differentiated tumors (G3), and
28 (55%) presented with concomitant carcinoma in
situ not necessarily localized unilaterally (Table 1).
Patients were followed according to our institutional
standard post-cystectomy protocol 3, 6, 12, 18 and 24
Fig. 1. Tumor localizations: (1) dome, (2) anterior wall, (3) right
lateral wall, (4) left lateral wall, (5) posterior wall (6), bladder
neck/trigone, (7) urethra. Only lymph node-positive bladder can-
cer patients with tumors strictly localized to the lateral wall (regions
(3) and (4) in the figure) were included in the study.
Table 1
Patient characteristics and pathological features of 51 lymph node-
positive patients with strictly unilateral muscle-invasive bladder
cancer
Sex; n (%)
Male 35 (69)
Female 16 (31)
Age; median (range), y 66.5 (43–87)
Pathologic tumor stage; n (%)
pT2a 1 (2)
pT2b 6 (12)
pT3a 17 (33)
pT3b 20 (39)
pT4 7 (14)
Pathologic tumor grade; n (%)
G2 2 (4)
G3 49 (96)
Concomitant carcinoma in situ; n (%)
Absent 23 (45)
Present 28 (55)
Histological type; n (%)
Squamous-cell carcinoma 2 (4)
Pure urothelial carcinoma 33 (65)
Variant histology in specimen 16 (31)
Squamous differentiation 5 (10)
Sarcomatoid differentiation 3 (6)
Other (nested, micropapillary, neuroendocrine) 8 (15)
Concomitant prostate cancer; n (%)
Absent 32 (63)
Present 19 (37)
LN metastases of prostate cancer 1 (2)
months postoperatively, and yearly thereafter. CT scan
and bone scan were performed 6, 12 and 24 months
postoperatively.
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Surgical technique
Extended PLND started in all patients at the level of
the crossing of the medialized ureter with the common
iliac artery and continued distally to the iliac bifurca-
tion (common iliac region) and along the external iliac
vessels to the inguinal ligament to include the node of
Cloquet bilaterally (external iliac region), as previously
described [4]. The anterolateral border of the dissection
field was the genito-femoral nerve. All tissue except the
obturator nerve was removed from the obturator fossa
(obturator region) and tissue removal was continued
proximally along the obturator nerve and lateral to the
iliac vessels to include the fossa of Marcille. Finally,
the lymphatic tissue on the internal iliac vessels and
their branches including the LNs medial to the internal
iliac artery (internal iliac region) was removed. The
excised tissue was fixed separately in neutral buffered
formalin (4%) and submitted in separate packages for
pathological evaluation. The cystectomy protocol was
reported in detail previously [14].
Pathological analysis
All specimens were processed and evaluated at the
Institute of Pathology, University of Bern, Switzerland.
Pathologists experienced in genitourinary pathology
examined the cystectomy specimens and nodal tissues.
No single pathologist examined all specimens but a
common protocol was used. The bladder was filled
with formalin and fixed at least overnight. Tumor
characteristics noted were localization, size, extent of
invasion, and multifocality. Sections for histology were
taken from the tumor(s), including the site of deep-
est macroscopic invasion, the anterior, posterior and
lateral walls of the bladder, the bladder neck with
trigone, the dome of the bladder, and any macro-
scopically abnormal area of the mucosa (Fig. 1). Any
residual ulcer after transurethral resection was sec-
tioned in toto. Histologically, tumor type, tumor grade,
tumor stage, the presence of vascular invasion, and
carcinoma-in-situ were assessed. LNs were identified
visually, by palpation, and by sectioning within each
package after tissue had been degreased with ace-
tone. All macroscopically detected LNs larger than
5 mm were cut into 2-mm to 4-mm-thick sections and
completely embedded in paraffin. If no LNs could be
identified, the entire tissue was embedded for histo-
logic examination. One section per paraffin block was
taken. The total number of LNs and the number bear-
ing metastases were recorded for each site separately.
Pathological staging was done according to the 1997
American Joint Committee on Cancer TNM classifi-
cation.
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 5 Software (GraphPad, San Diego, CA). Local
recurrences and distal metastases were compared using
the chi-square test. Further results are purely descrip-
tive due to the small patient sample size. Statistical
significance was set at p < 0.05.
RESULTS
A total of 1814 LNs (median 35 LNs; range: 13–80
LNs) were removed and examined in the 51 pN+
patients with strictly unilateral BC (Table 2). Of these
1814 LNs, 145 (8%) showed metastases upon patho-
logical examination. The distribution of all positive
LNs is shown in Fig. 2. The median number of posi-
tive LNs per patient was 2 (range: 1–14). Twenty-five
of the 145 positive LNs (17%) showed extracapsular
extension of the LN metastasis. Fourteen of the 51
pN+ patients (27%) presented with LN metastases on
the contralateral side (cross-over). The total number
of positive contralateral LNs was 18 (median 1 LN
per patient; range: 1–3). Of the 18 positive contralat-
eral LNs, 13 (72%) were located in the external iliac
(region I), 3 (17%) in the obturator fossa (region II),
and 2 (11%) in the common iliac region (region IV).
Not a single LN metastasis was found in the contralat-
eral internal iliac region (region III) or the contralateral
fossa of Marcille (region V) (Fig. 2). Five of the 51
pN+ patients (10%) showed LN metastases only in
contralateral LNs without metastases to LNs in the
ipsilateral pelvis (total LNs: 7; external iliac: 3 [42%];
common iliac: 1 [14%]; obturator fossa: 3 [42%]).
Table 2
Distribution of the 1814 LNs resected in 51 patients
n % median IQR
Ipsilateral 966 53
– external iliac 454 25 7 4.5–12
– obturator fossa 218 12 4 2–6
– internal iliac 145 8 3 1–5
– common iliac 99 5 2 1–4
– fossa of Marcille 50 3 1 0–3
Contralateral 848 47
– external iliac 460 25 8 4–12
– obturator fossa 197 12 4 2–5
– internal iliac 106 6 2.5 1–4
– common iliac 62 3 1.5 0–4
– fossa of Marcille 23 1 0.5 0–1.5
IQR: Interquartile range
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ipsilateral (n) 58 10 33 15 10
contralateral (n) 13 3 0 3 0
Fig. 2. Schematic diagram showing the distribution of lymph node metastases (n = 145) of the lateral bladder walls (left and right) projected to
a single side (right; asterisk). The pelvic lymph node dissection boundaries are subdivided into the (I) external iliac, (II) obturator fossa, (III)
internal iliac, (IV) common iliac, and (V) fossa of Marcille regions.
One of the 51 pN+ patients with strictly unilateral
BC (2%) developed a local recurrence during follow
up versus 5 of 142 pN+ patients with BC localization
other than strictly unilateral (3.5%; p = 0.58); distant
metastases were seen in 10 of 51 (20%) of the former
patients and 30 of 142 (21%) of the latter (p = 0.82).
DISCUSSION
Extended PLND and radical cystectomy are the gold
standard in the management of muscle-invasive BC.
More and more data is being gathered confirming the
benefit of a meticulous PLND in terms of recurrence-
free survival and overall survival [3, 15, 16]. Still,
there is controversy regarding the optimal extent of
the PLND template - especially the proximal border.
In their comparative cystectomy series, Zehnder et al.
[3] showed similar survival and recurrence rates in
pT2-3 cN0 cM0 BC patients receiving a meticulous
ePLND up to the mid upper third of the common iliac
vessel as compared to a super-extended template up
to the inferior mesenteric artery. This was the first
time it could be shown that more is not always bet-
ter in PLND for BC. In line with these considerations
and the results of a dynamic mapping study of Roth
et al. [4], our pathoanatomical validation study cor-
roborates the hypothesis that there is no lymphatic
drainage to the contralateral internal iliac region in
patients with strictly unilateral BC. To confirm that
PLND of the contralateral internal iliac region can
be safely omitted in these patients, however, would
require multi-center validation. Preferably, this should
be done in a prospective protocol evaluating the sur-
vival of patients with strictly unilateral tumors who
undergo ePLND versus patients who undergo ePLND
that excludes the contralateral internal iliac region.
Alternatively, a prospective multi-center study could
be conducted with careful documentation of locations
of the primary tumor (bladder mapping) and of nodal
metastases to evaluate the true incidence and location
of ipsilateral and contralateral metastases.
To date little attention has been paid to the relation
of the primary tumor site within the bladder to the site
of metastatic deposit. Literature on intravesical tumor
location and oncological parameters is sparse. More-
over, the available data are mutually conflicting [10,
17, 18]. In addition none of the published trials inves-
tigated the primary lymphatic landing sites with regard
to tumor location. More recently, Svatek et al. found
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that tumor involvement of the trigone is associated with
a greater risk of LN metastases and an unfavorable
cancer-specific survival, but no other tumor location
(especially the lateral wall) was found to be associated
with an increased risk of LN involvement [19]. In our
cohort, however, local recurrence and distal metasta-
sis rates in pN+ patients with strictly unilateral BC did
not differ significantly from those in pN+ patients with
other BC locations (2% vs. 3.5%, p = 0.58; 20% and
21%, p = 0.82, respectively).
Crossover LN metastases was found in 27% of our
pN+ patients with strictly unilaterally localized BC.
This finding accords with earlier pathoanatomical stud-
ies [10, 20] showing contralateral LN metastases in
15.5% to 41% of patients with unilateral BC. Most
importantly, 10% (5/51) of our pN+ patients with uni-
lateral BC had LN metastases on the contralateral
side only. This number is lower than the 23% (3/13)
of patients with unilateral BC in the study of Leiss-
ner et al. [20]. Indeed, they included not only strictly
unilateral tumors but tumors localized in a single blad-
der hemisphere, thus most probably including tumors
involving the bladder neck, trigone, and/or posterior
bladder wall – regions within the bladder that are well
known to have ubiquitous lymphatic drainage [4, 19].
The finding that 27% of our patients had bilateral and
10% had contralateral metastases only shows once
again that bilateral PLND is an oncological cornerstone
of surgery for BC.
This study has limitations beyond the inherent short-
comings of any retrospective study. Although our
pathoanatomical study examines a relatively large
cohort of pN+ BC patients (n = 193), the sample size
of 51 pN+ patients with strictly unilateral BC is rela-
tively small. Still, our data corroborate the finding of
a dynamic LN mapping study that lymphatic drainage
to the contralateral internal iliac region is absent in
strictly unilateral tumors [4]; there was not a single
LN metastasis in the contralateral internal iliac region,
not even in patients with high tumor stage / grade and
high LN metastatic burden. This appears to contrast
with the finding by Leissner et al. of some positive
nodes in the contralateral internal iliac region [20].
Indeed, in that study they examined tumors located in
a single bladder hemisphere including tumors involv-
ing the bladder neck, trigone, and/or posterior bladder
wall, regions well known to drain everywhere within
the pelvis [4, 19].
Another limitation of the present study is that no
prospective or retrospective data on LN sparing in
the internal iliac region are yet available. Neverthe-
less, the possible functional benefits are a logical
conclusion based on anatomical and functional studies.
The branches of the pelvic plexus (comprised of sym-
pathetic and parasympathetic fibres) [21] are in close
proximity to the (medial) internal iliac region. Omis-
sion of LN dissection in this internal iliac region (on
the side contralateral to the tumor) should minimize
damage to the fragile autonomic nerves which appear
to be important for innervation of the proximal urethra
(continence) [22, 23]; such nerve sparing may have
a beneficial impact on continence after radical cysto-
prostatectomy and ileal orthotopic bladder substitution
[8, 24, 25] although there is no direct evidence for
this yet. These clinical data accord with intraoperative
electrophysiological findings and animal studies [12,
26]. Moreover, nerve sparing also appears to safeguard
erectile function by preserving parasympathetic fibres
passing through the plexus pelvicus [6–8, 11, 27–29]. It
is, however, not only the preservation of the neurovas-
cular bundle that makes the omission of LN dissection
in the (medial) internal iliac region appealing for the
improvement of postoperative functional results, but
also the potential further decrease in devasculariza-
tion (damage to internal iliac vessel branches) in this
region with concomitant less ischemia and necrosis
[11]. Nerve sparing is of utmost importance not only in
terms of better functional results of subsequent ortho-
topic bladder substitution or better recovery of sexual
function, but also as a means to avert potential prob-
lems of defecation [30]. As the present results indicate,
this may be done without compromising oncological
radicality. Prospective evaluation (preferably multi-
center), however, has to confirm this hypothesis.
Another limitation of this study is the difficulty with
assigning tumor location in a retrospective study. We
did, however, look not only at pathology reports but
also at (preoperative) cystoscopy reports. Furthermore,
imaging data were all re-reviewed. Therefore, we think
that the risk of “mis-assignment” of tumor locations
was minimal.
In conclusion, our pathoanatomical validation study
corroborates the data of a dynamic mapping study
showing a lack of lymphatic drainage to the con-
tralateral internal iliac region in patients with strictly
unilateral BC. If these results can be confirmed in
a prospective evaluation – preferably a multi-center
study - contralateral pelvic lymph node dissection
could then be limited to the obturator fossa and the
external and common iliac regions in this highly
selected group of patients with strictly unilateral tumor
growth. This would better preserve the contralateral
autonomic nerves situated close and medial to the inter-
nal iliac vessels.
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